An overview of age-specific pharmacokinetics and pharmacodynamics

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The body's handling of drugs can be significantly altered with age. An overview of the way the body manages the movement of drugs through the body, pharmacokinetics, and their interaction with the body to cause their effects, pharmacodynamics, is provided. Clinically significant changes rather than those seen only in laboratory-controlled conditions are stressed. Some specific drug categories that present increased risk for older patients (psychoactive drugs, non-steroidal anti-inflammatory drugs, histamine-2 antagonists and warfarin) are reviewed in detail. In summary, there are numerous changes in drug pharmacokinetics and pharmacodynamics with aging. Some of these can be clinically significant, causing adverse effects or lack of clinical efficacy. Knowledge of the mechanisms, and specific drugs at- risk, will enable practitioners successfully to prescribe drugs even from the high-risk categories.

Original languageEnglish (US)
Pages (from-to)81-86
Number of pages6
JournalAging Male
Volume3
Issue number2
StatePublished - 2000
Externally publishedYes

Fingerprint

Pharmacokinetics
Pharmaceutical Preparations
Histamine Antagonists
Psychotropic Drugs
Warfarin
Anti-Inflammatory Agents

Keywords

  • Drug therapy
  • Elderly
  • Geriatric
  • Pharmacodynamic
  • Pharmacokinetic

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

An overview of age-specific pharmacokinetics and pharmacodynamics. / McDonagh, Marian.

In: Aging Male, Vol. 3, No. 2, 2000, p. 81-86.

Research output: Contribution to journalArticle

@article{5eee9052557d4b92a8dd7300567c1573,
title = "An overview of age-specific pharmacokinetics and pharmacodynamics",
abstract = "The body's handling of drugs can be significantly altered with age. An overview of the way the body manages the movement of drugs through the body, pharmacokinetics, and their interaction with the body to cause their effects, pharmacodynamics, is provided. Clinically significant changes rather than those seen only in laboratory-controlled conditions are stressed. Some specific drug categories that present increased risk for older patients (psychoactive drugs, non-steroidal anti-inflammatory drugs, histamine-2 antagonists and warfarin) are reviewed in detail. In summary, there are numerous changes in drug pharmacokinetics and pharmacodynamics with aging. Some of these can be clinically significant, causing adverse effects or lack of clinical efficacy. Knowledge of the mechanisms, and specific drugs at- risk, will enable practitioners successfully to prescribe drugs even from the high-risk categories.",
keywords = "Drug therapy, Elderly, Geriatric, Pharmacodynamic, Pharmacokinetic",
author = "Marian McDonagh",
year = "2000",
language = "English (US)",
volume = "3",
pages = "81--86",
journal = "Aging Male",
issn = "1368-5538",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - An overview of age-specific pharmacokinetics and pharmacodynamics

AU - McDonagh, Marian

PY - 2000

Y1 - 2000

N2 - The body's handling of drugs can be significantly altered with age. An overview of the way the body manages the movement of drugs through the body, pharmacokinetics, and their interaction with the body to cause their effects, pharmacodynamics, is provided. Clinically significant changes rather than those seen only in laboratory-controlled conditions are stressed. Some specific drug categories that present increased risk for older patients (psychoactive drugs, non-steroidal anti-inflammatory drugs, histamine-2 antagonists and warfarin) are reviewed in detail. In summary, there are numerous changes in drug pharmacokinetics and pharmacodynamics with aging. Some of these can be clinically significant, causing adverse effects or lack of clinical efficacy. Knowledge of the mechanisms, and specific drugs at- risk, will enable practitioners successfully to prescribe drugs even from the high-risk categories.

AB - The body's handling of drugs can be significantly altered with age. An overview of the way the body manages the movement of drugs through the body, pharmacokinetics, and their interaction with the body to cause their effects, pharmacodynamics, is provided. Clinically significant changes rather than those seen only in laboratory-controlled conditions are stressed. Some specific drug categories that present increased risk for older patients (psychoactive drugs, non-steroidal anti-inflammatory drugs, histamine-2 antagonists and warfarin) are reviewed in detail. In summary, there are numerous changes in drug pharmacokinetics and pharmacodynamics with aging. Some of these can be clinically significant, causing adverse effects or lack of clinical efficacy. Knowledge of the mechanisms, and specific drugs at- risk, will enable practitioners successfully to prescribe drugs even from the high-risk categories.

KW - Drug therapy

KW - Elderly

KW - Geriatric

KW - Pharmacodynamic

KW - Pharmacokinetic

UR - http://www.scopus.com/inward/record.url?scp=0033939590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033939590&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033939590

VL - 3

SP - 81

EP - 86

JO - Aging Male

JF - Aging Male

SN - 1368-5538

IS - 2

ER -